Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
52
UFPT Quote, Financials, Valuation and Earnings
Last price:
$251.15
Seasonality move
:
11.37%
Day range:
$251.63 - $270.64
52-week range:
$178.26 - $275.81
Dividend yield:
0%
P/E ratio:
30.54x
P/S ratio:
3.43x
P/B ratio:
5.03x
Volume:
156.3K
Avg. volume:
162.5K
1-year change:
0.56%
Market cap:
$2B
Revenue:
$504.4M
EPS (TTM):
$8.63
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
UFPT
UFP Technologies, Inc.
|
$149.1M | $2.24 | 3.47% | 6.38% | $329.50 |
|
ABT
Abbott Laboratories
|
$11.8B | $1.49 | 6.14% | 54.88% | $133.39 |
|
ARAY
Accuray, Inc.
|
$100.9M | -$0.11 | -1.19% | -296.83% | $2.53 |
|
ISRG
Intuitive Surgical, Inc.
|
$2.8B | $2.27 | 16.41% | 10.87% | $611.82 |
|
MASI
Masimo Corp.
|
$408M | $1.49 | 7.08% | 565.51% | $183.75 |
|
PSTV
Plus Therapeutics, Inc.
|
$1.2M | -$0.04 | 22.78% | -97.49% | $5.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
UFPT
UFP Technologies, Inc.
|
$263.44 | $329.50 | $2B | 30.54x | $0.00 | 0% | 3.43x |
|
ABT
Abbott Laboratories
|
$113.59 | $133.39 | $197.5B | 30.67x | $0.63 | 2.11% | 4.48x |
|
ARAY
Accuray, Inc.
|
$0.51 | $2.53 | $58.1M | 149.00x | $0.00 | 0% | 0.13x |
|
ISRG
Intuitive Surgical, Inc.
|
$496.12 | $611.82 | $176.2B | 62.99x | $0.00 | 0% | 17.88x |
|
MASI
Masimo Corp.
|
$135.04 | $183.75 | $7.3B | 116.80x | $0.00 | 0% | 4.27x |
|
PSTV
Plus Therapeutics, Inc.
|
$0.27 | $5.50 | $37.3M | -- | $0.00 | 0% | 4.35x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
UFPT
UFP Technologies, Inc.
|
29.07% | 1.404 | 10.75% | 1.27x |
|
ABT
Abbott Laboratories
|
20.25% | 0.141 | -- | 1.12x |
|
ARAY
Accuray, Inc.
|
76.53% | 1.394 | 186.42% | 0.52x |
|
ISRG
Intuitive Surgical, Inc.
|
0.95% | 0.941 | 0.08% | 3.73x |
|
MASI
Masimo Corp.
|
41.99% | 0.815 | 7.4% | 1.68x |
|
PSTV
Plus Therapeutics, Inc.
|
0.41% | -1.387 | 0.02% | 1.22x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
UFPT
UFP Technologies, Inc.
|
$42.7M | $23.7M | 11.98% | 18.42% | 15.32% | $32.5M |
|
ABT
Abbott Laboratories
|
$6.5B | $2.4B | 10.2% | 29.06% | 20.59% | $2.3B |
|
ARAY
Accuray, Inc.
|
$24.1M | -$5.5M | -14.23% | -60.6% | -5.37% | $8.4M |
|
ISRG
Intuitive Surgical, Inc.
|
$1.9B | $864.3M | 16.53% | 16.59% | 30.16% | $730M |
|
MASI
Masimo Corp.
|
$230.6M | $83.7M | -11.41% | -19.18% | 22.53% | $49.7M |
|
PSTV
Plus Therapeutics, Inc.
|
$1.3M | -$4.5M | -- | -- | -320.83% | -$2.6M |
UFP Technologies, Inc. vs. Competitors
-
Which has Higher Returns UFPT or ABT?
Abbott Laboratories has a net margin of 10.6% compared to UFP Technologies, Inc.'s net margin of 15.5%. UFP Technologies, Inc.'s return on equity of 18.42% beat Abbott Laboratories's return on equity of 29.06%.
Company Gross Margin Earnings Per Share Invested Capital UFPTUFP Technologies, Inc.27.66% $2.11 $569.4M ABTAbbott Laboratories57.09% $1.02 $64.2B -
What do Analysts Say About UFPT or ABT?
UFP Technologies, Inc. has a consensus price target of $329.50, signalling upside risk potential of 25.08%. On the other hand Abbott Laboratories has an analysts' consensus of $133.39 which suggests that it could grow by 17.43%. Given that UFP Technologies, Inc. has higher upside potential than Abbott Laboratories, analysts believe UFP Technologies, Inc. is more attractive than Abbott Laboratories.
Company Buy Ratings Hold Ratings Sell Ratings UFPTUFP Technologies, Inc.1 2 0 ABTAbbott Laboratories15 7 0 -
Is UFPT or ABT More Risky?
UFP Technologies, Inc. has a beta of 1.106, which suggesting that the stock is 10.601% more volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.749, suggesting its less volatile than the S&P 500 by 25.138%.
-
Which is a Better Dividend Stock UFPT or ABT?
UFP Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 2.11% to investors and pays a quarterly dividend of $0.63 per share. UFP Technologies, Inc. pays -- of its earnings as a dividend. Abbott Laboratories pays out 64.34% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios UFPT or ABT?
UFP Technologies, Inc. quarterly revenues are $154.6M, which are smaller than Abbott Laboratories quarterly revenues of $11.5B. UFP Technologies, Inc.'s net income of $16.4M is lower than Abbott Laboratories's net income of $1.8B. Notably, UFP Technologies, Inc.'s price-to-earnings ratio is 30.54x while Abbott Laboratories's PE ratio is 30.67x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UFP Technologies, Inc. is 3.43x versus 4.48x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UFPTUFP Technologies, Inc.3.43x 30.54x $154.6M $16.4M ABTAbbott Laboratories4.48x 30.67x $11.5B $1.8B
-
Which has Higher Returns UFPT or ARAY?
Accuray, Inc. has a net margin of 10.6% compared to UFP Technologies, Inc.'s net margin of -13.47%. UFP Technologies, Inc.'s return on equity of 18.42% beat Accuray, Inc.'s return on equity of -60.6%.
Company Gross Margin Earnings Per Share Invested Capital UFPTUFP Technologies, Inc.27.66% $2.11 $569.4M ARAYAccuray, Inc.23.54% -$0.11 $227.6M -
What do Analysts Say About UFPT or ARAY?
UFP Technologies, Inc. has a consensus price target of $329.50, signalling upside risk potential of 25.08%. On the other hand Accuray, Inc. has an analysts' consensus of $2.53 which suggests that it could grow by 392.88%. Given that Accuray, Inc. has higher upside potential than UFP Technologies, Inc., analysts believe Accuray, Inc. is more attractive than UFP Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings UFPTUFP Technologies, Inc.1 2 0 ARAYAccuray, Inc.2 0 0 -
Is UFPT or ARAY More Risky?
UFP Technologies, Inc. has a beta of 1.106, which suggesting that the stock is 10.601% more volatile than S&P 500. In comparison Accuray, Inc. has a beta of 1.151, suggesting its more volatile than the S&P 500 by 15.124%.
-
Which is a Better Dividend Stock UFPT or ARAY?
UFP Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Accuray, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UFP Technologies, Inc. pays -- of its earnings as a dividend. Accuray, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UFPT or ARAY?
UFP Technologies, Inc. quarterly revenues are $154.6M, which are larger than Accuray, Inc. quarterly revenues of $102.2M. UFP Technologies, Inc.'s net income of $16.4M is higher than Accuray, Inc.'s net income of -$13.8M. Notably, UFP Technologies, Inc.'s price-to-earnings ratio is 30.54x while Accuray, Inc.'s PE ratio is 149.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UFP Technologies, Inc. is 3.43x versus 0.13x for Accuray, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UFPTUFP Technologies, Inc.3.43x 30.54x $154.6M $16.4M ARAYAccuray, Inc.0.13x 149.00x $102.2M -$13.8M
-
Which has Higher Returns UFPT or ISRG?
Intuitive Surgical, Inc. has a net margin of 10.6% compared to UFP Technologies, Inc.'s net margin of 27.89%. UFP Technologies, Inc.'s return on equity of 18.42% beat Intuitive Surgical, Inc.'s return on equity of 16.59%.
Company Gross Margin Earnings Per Share Invested Capital UFPTUFP Technologies, Inc.27.66% $2.11 $569.4M ISRGIntuitive Surgical, Inc.66.41% $2.21 $18.1B -
What do Analysts Say About UFPT or ISRG?
UFP Technologies, Inc. has a consensus price target of $329.50, signalling upside risk potential of 25.08%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $611.82 which suggests that it could grow by 23.32%. Given that UFP Technologies, Inc. has higher upside potential than Intuitive Surgical, Inc., analysts believe UFP Technologies, Inc. is more attractive than Intuitive Surgical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings UFPTUFP Technologies, Inc.1 2 0 ISRGIntuitive Surgical, Inc.16 10 1 -
Is UFPT or ISRG More Risky?
UFP Technologies, Inc. has a beta of 1.106, which suggesting that the stock is 10.601% more volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.653, suggesting its more volatile than the S&P 500 by 65.303%.
-
Which is a Better Dividend Stock UFPT or ISRG?
UFP Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UFP Technologies, Inc. pays -- of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UFPT or ISRG?
UFP Technologies, Inc. quarterly revenues are $154.6M, which are smaller than Intuitive Surgical, Inc. quarterly revenues of $2.9B. UFP Technologies, Inc.'s net income of $16.4M is lower than Intuitive Surgical, Inc.'s net income of $799.5M. Notably, UFP Technologies, Inc.'s price-to-earnings ratio is 30.54x while Intuitive Surgical, Inc.'s PE ratio is 62.99x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UFP Technologies, Inc. is 3.43x versus 17.88x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UFPTUFP Technologies, Inc.3.43x 30.54x $154.6M $16.4M ISRGIntuitive Surgical, Inc.17.88x 62.99x $2.9B $799.5M
-
Which has Higher Returns UFPT or MASI?
Masimo Corp. has a net margin of 10.6% compared to UFP Technologies, Inc.'s net margin of 14.46%. UFP Technologies, Inc.'s return on equity of 18.42% beat Masimo Corp.'s return on equity of -19.18%.
Company Gross Margin Earnings Per Share Invested Capital UFPTUFP Technologies, Inc.27.66% $2.11 $569.4M MASIMasimo Corp.62.07% -$1.86 $1.4B -
What do Analysts Say About UFPT or MASI?
UFP Technologies, Inc. has a consensus price target of $329.50, signalling upside risk potential of 25.08%. On the other hand Masimo Corp. has an analysts' consensus of $183.75 which suggests that it could grow by 36.07%. Given that Masimo Corp. has higher upside potential than UFP Technologies, Inc., analysts believe Masimo Corp. is more attractive than UFP Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings UFPTUFP Technologies, Inc.1 2 0 MASIMasimo Corp.4 3 0 -
Is UFPT or MASI More Risky?
UFP Technologies, Inc. has a beta of 1.106, which suggesting that the stock is 10.601% more volatile than S&P 500. In comparison Masimo Corp. has a beta of 1.262, suggesting its more volatile than the S&P 500 by 26.165%.
-
Which is a Better Dividend Stock UFPT or MASI?
UFP Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Masimo Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UFP Technologies, Inc. pays -- of its earnings as a dividend. Masimo Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UFPT or MASI?
UFP Technologies, Inc. quarterly revenues are $154.6M, which are smaller than Masimo Corp. quarterly revenues of $371.5M. UFP Technologies, Inc.'s net income of $16.4M is lower than Masimo Corp.'s net income of $53.7M. Notably, UFP Technologies, Inc.'s price-to-earnings ratio is 30.54x while Masimo Corp.'s PE ratio is 116.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UFP Technologies, Inc. is 3.43x versus 4.27x for Masimo Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UFPTUFP Technologies, Inc.3.43x 30.54x $154.6M $16.4M MASIMasimo Corp.4.27x 116.80x $371.5M $53.7M
-
Which has Higher Returns UFPT or PSTV?
Plus Therapeutics, Inc. has a net margin of 10.6% compared to UFP Technologies, Inc.'s net margin of -316.61%. UFP Technologies, Inc.'s return on equity of 18.42% beat Plus Therapeutics, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital UFPTUFP Technologies, Inc.27.66% $2.11 $569.4M PSTVPlus Therapeutics, Inc.93.84% -$0.04 $5.1M -
What do Analysts Say About UFPT or PSTV?
UFP Technologies, Inc. has a consensus price target of $329.50, signalling upside risk potential of 25.08%. On the other hand Plus Therapeutics, Inc. has an analysts' consensus of $5.50 which suggests that it could grow by 1928.02%. Given that Plus Therapeutics, Inc. has higher upside potential than UFP Technologies, Inc., analysts believe Plus Therapeutics, Inc. is more attractive than UFP Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings UFPTUFP Technologies, Inc.1 2 0 PSTVPlus Therapeutics, Inc.4 0 0 -
Is UFPT or PSTV More Risky?
UFP Technologies, Inc. has a beta of 1.106, which suggesting that the stock is 10.601% more volatile than S&P 500. In comparison Plus Therapeutics, Inc. has a beta of 0.886, suggesting its less volatile than the S&P 500 by 11.364%.
-
Which is a Better Dividend Stock UFPT or PSTV?
UFP Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Plus Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UFP Technologies, Inc. pays -- of its earnings as a dividend. Plus Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UFPT or PSTV?
UFP Technologies, Inc. quarterly revenues are $154.6M, which are larger than Plus Therapeutics, Inc. quarterly revenues of $1.4M. UFP Technologies, Inc.'s net income of $16.4M is higher than Plus Therapeutics, Inc.'s net income of -$4.4M. Notably, UFP Technologies, Inc.'s price-to-earnings ratio is 30.54x while Plus Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UFP Technologies, Inc. is 3.43x versus 4.35x for Plus Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UFPTUFP Technologies, Inc.3.43x 30.54x $154.6M $16.4M PSTVPlus Therapeutics, Inc.4.35x -- $1.4M -$4.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
40
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
91
TDC alert for Feb 12
Teradata Corp. [TDC] is down 11.64% over the past day.
Buy
67
DIOD alert for Feb 12
Diodes, Inc. [DIOD] is down 7.63% over the past day.
Buy
77
VRT alert for Feb 12
Vertiv Holdings Co. [VRT] is down 4.79% over the past day.
